MarketsandMarkets

Next-Gen Immuno-Oncology Conference - West Coast Edition

8th - 9th February 2024

Double Tree by Hilton, San Diego - Mission Valley | 7450 Hazard Centre Drive San Diego, CA

Avail Your Ticket Avail
Your Ticket
Become A Sponsor Become
A Sponsor
Become A Speaker Become
A Speaker

EVENT OVERVIEW

Empowering Patients, Defying Cancer: Next-Gen Immuno-Oncology at the Forefront of Medicine

Join us at the MarketsandMarkets Next-Gen Immuno-Oncology Conference - West Coast Edition, the premier gathering of leading experts and professionals in the field of immuno-oncology. Taking place on the 8th - 9th February 2024 in San Diego, USA, this conference is a must-attend event for anyone passionate about shaping the future of cancer treatment.

The Immuno-Oncology Conference brings together renowned researchers, clinicians, industry leaders, and policy makers to explore the latest advancements and breakthroughs in immuno-oncology. With a focus on next-generation approaches and cutting-edge innovations, the conference provides a platform for networking, knowledge exchange, and collaboration.

Be prepared to immerse yourself in two days of inspiring keynotes, interactive panel discussions, and informative sessions covering a wide range of topics in immuno-oncology. From exploring novel therapeutics and personalized treatment strategies to discussing regulatory challenges and market trends, the Immuno-Oncology Congress offers a comprehensive and holistic perspective on the field. Don't miss this opportunity to be part of the dynamic Immuno-Oncology Summit that will shape the future of cancer care. Register today to secure your spot and join the global community driving progress and inspiring hope in immuno-oncology.

CO-LOCATED CONFERENCES

6th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference
9th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference - West Coast Edition

WHAT TO EXPECT

  • Latest updates on ADC’s and Bispecific Ab’s development
  • Immune Checkpoint Inhibitors and Combination therapies advancements
  • Get insights into preclinical and translational Immuno-Oncology developments, including immune checkpoint modulator preclinical models.
  • Biomarkers and personalized medicine in Immuno-Oncology
  • Potential of CAR-T Cell therapy and TCR Based-Cell Therapy
  • Impact of the Tumor microenvironment and Oncolytic Viruses

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

  • Monoclonal and Bispecific Antibodies
  • Cell Therapy
  • Immune Checkpoint Inhibitors

  • Discover advancements in antibodies, cellular therapy, and immune-checkpoint research all under one roof
  • Stay informed about the latest case studies on ongoing immune oncology projects
  • Engage in interactive roundtables with your peers to discuss and explore relevant topics in-depth
  • Explore cutting-edge platforms and technologies available for development in the field
  • Exchange insights and discuss the optimal research tools for immune oncology studies
  • Showcase your work and accomplishments to industry peers in the Poster Session

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by